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T-cell receptor (TCR) ]/-chain usage and expression of the CD3, CD4, and CD8
differentiation antigens were analyzed in 14 spontaneous AKR lymphomas. Lymphoma
cells massively infiltrated and/or proliferated in the organs analyzed (thymus, spleen,
and mesenteric lymph nodes), giving rise to a loss of organ structure. One lymphoma
occurred only in the thymus, and failed to express CD3, CD4, and CD8. All other
lymphomas expressed the CD3/TCR complex. With respect to CD4 and CD8
expression, the lymphomas were either double-negative (DN), double-positive (DP), or
single-positive (SP). The frequency of DP (CD4/8+) lymphomas was low compared to the
frequency of DP thymocytes in a normal AKR thymus. A substantial heterogeneity was
seen in the intensity of CD4 and CD8 expression among various lymphomas, which was
independent of the level of CD3 expression. Considering TCR V]/gene family usage, 2
out of 14 lymphomas expressed V]/6. Normally, V]/6 thymocytes are deleted from the
thymocyte pool at the immature DP stage of T-cell development in AKR mice. These
data support the hypothesis that the lymphocytes in the immature DP stage of T-cell
development are susceptible to the induction of AKR lymphomagenesis. The presence
of V6 lymphoma cells indicates that the lymphomagenesis is accompanied by a
defective clonal deletion of cells expressing a possible autoreactive TCR.
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INTRODUCTION
AKR mice have a high incidence of spontaneous
(thymic) lymphomas that develop after the
appearance of a functional polytropic retrovirus.
The thymus appears to be the most common site
of this neoplastic process, and is in some cases
the only organ involved. The crucial role of the
thymus in the lymphomagenesis is also shown
because the incidence of lymphomas is decreased
after thymectomy in young healthy mice (1-2
months old), but not after splenectomy. Both the
stationary (epithelial) and bone marrow-derived
(macrophage, dendritic) stromal components of
the thymic microenvironment have been claimed
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to contribute to the lymphomagenesis (Tempelis,
1987; Kim et al., 1991). Thymic macrophages in
the corticomedullary region are the first cells in
which detectable levels of functional polytropic
retrovirus are found (Kim et al., 1991). On the
other hand, also the radioresistant thymic epi-
thelial cells are able to amplify or suppress
expression of AKR retroviruses and the prelym-
phomic phenotypical changes (Tempelis, 1987).
The developmental stage, in which the differen-
tiating thymocytes become susceptible to the
induction of the lymphomagenesis, is neverthe-
less not known.
The epithelial and bone marrow-derived cells
in the thymus also play an important role in
shaping the repertoire of mature peripheral T
cells. Thymocyte maturation involves positive
and negative selection processes that generate
mature T cells that are both self-tolerant as well
as able to recognize antigen in the context of self-
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major histocompatibility complex (MHC) deter-
minants (Ramsdell and Fowlkes, 1990). Inter-
actions between developing T cells and stromal
elements in the thymus are essential for these
processes. The CD3/T-cell antigen receptor com-
plex, MHC determinants, and the CD4 or CD8
differentiation antigens are involved in these
interactions (Ramsdell and Fowlkes, 1990).
AKR mice have the minor lymphocyte stimu-
latory locus-1 (Mls-1 a) phenotype. Mls-1 was
considered a minor histocompatibility antigen,
but has recently been identified as an endogen-
ous retroviral antigen (Frankel et al., 1991).
Mls-1 mice are deleting their Mls-1 reactive T
lymphocytes during intrathymic maturation
(Kappler et al., 1988; MacDonald et al., 1988a;
Happ et al., 1989), that is, T cells expressing the
V//6, Vfl8.1 or V//9 variable gene segments of the
//chain of the T-cell receptor (TCR). The response
to Mls-1 is restricted to MHC class II, and the
CD4
/ T-cell subset is the presumed autoreactive
population. It was shown that V//6+CD8
+ T lym-
phocytes alone do not give an anti-Mls-1 pro-
liferative response in vitro, and need the help of
CD4/T cells (MacDonald et al., 1988a; Webb and
Sprent, 1990). However, all T cells expressing
these TCR are expected to be deleted from the
thymocyte pool of the AKR thymus (MacDonald
et al., 1988a) at the immature double-positive
(DP) stage of T-cell development (Blackman et
al., 1990b; Matsuaki et al., 1990; Ramsdell and
Fowlkes, 1990). This results in the absence of
V//6, V//8.1, and V]39 expressing CD4
/ and CD8
/
single-positive (SP) T cells in the mature thymo-
cyte and peripheral T-cell populations of normal
AKR mice (MacDonald et al., 1988a; Webb and
Sprent, 1990). Rearrangement of the Vfl6 gene has
been described in one AKR lymphoma (Lee and
Davis, 1988), but it has not been documented
whether this rearrangement was functional and
resulted in the expression of Vfl6 on the cell
surface.
We analyzed 14 naturally occurring AKR lym-
phomas using monoclonal antibodies (mAB) to
the CD3, CD4, and CD8 differentiation antigens,
and to TCR //-chain variable region segments
V]33, Vfl6, and V/J8.1/2. This latter mAB recog-
nizes an epitope shared by V]38.1 and V]38.2, but
not other members of the Vfl8 family. Our data
indicate that the immature DP (CD4/8+) thymo-
cyte is the most likely target for AKR lymphom-
agenesis. The lymphomagenesis is accompanied
by defects in the clonal deletion of lymphoma
cells that express autoreactive TCR.
RESULTS
The greatly enlarged lymphoid organs (thymus,
spleen, mesenteric lymph nodes) of the lym-
phomic AKR mice showed lymphoma cells in
thymus, spleen, and lymph nodes in all but one
of the AKR mice. In one case (case 11), the lym-
phoma was present in the thymus only. In the
lymphoid tissues of some of the lymphoma-
bearing animals, remnants of the preexistent
organ structure were observed. In the majority of
cases, there was a massive infiltration and/or
proliferation of lymphoma cells with a loss of the
normal structure of the lymphoid organs.
In immunohistochemistry for CD3/TCR com-
plex; CD4, and CD8, all but one of the lym-
phomas expressed the CD3/TCR complex indi-
cating the T-cell lineage origin of the lymphomas.
Staining for CD4 and CD8 enabled identification
of lymphomas with a double-negative (DN), DP,
and SP phenotype (Table 1). The frequencies of
these phenotypes differ from that in the normal
AKR thymus, with a shift to the more mature SP
phenotypes (Table 1). The intensity of CD4 and
CD8 expression varied widely between individ-
ual lymphomas, independently of the intensity of
TABLE
CD3/TCR and CD4/CD8 Expression on Thymic Lymphomas
in AKR Mice
Case CD4 CD8 CD3/T-cell receptor
lb +
2 +
5 +
13 +ow
4a +high + V6
4b +low +high V/8.1/2
6 + +
7 +ow + Vfl8.1/2
14 + + V//6
15 +low +
lab + +
9 + +
10 + + V//3
8 + +low +low
12 +high + + V]/8.1/2
""High" and "low" indicate expression intensities that significantly higher
lower than the average intensity.
bCases and of biclonal origin; the clones designated and b.
These clones not overlapping, i.e., cells expressing Vfl6 and Vfl8.1/2
localized at different positions in immunohistology (Fig. 1).
CAll KJ16-positive AKR lymphomas expressed the Vf18.2 gene segment shown
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CD3/TCR-complex expression (Table 1). Staining
with the anti-CD3 mAB YCD3-1 revealed a rare
thymic phenotype in four of the DN lymphomas;
these four cases expressed CD3 at a readily
detectable intensity. The one CD3-negative lym-
phoma case corresponded to a presumed imma-
ture triple-negative stage (CD3-4-8-) of T-cell
development.
Further examination of the primary lym-
phomas with mABs to Vfl gene family products
of the TCR revealed a large difference in Vfl
usage between the lymphoma cases and normal
AKR thymocytes or peripheral T lymphocytes.
Five out of 14 lymphomas were positive for Vfl3,
Vfl6, or Vfl8.1/2 (Tabl.e 1), whereas the other lym-
phomas were negative for these families. One
lymphoma (case 10) expressed Vfl3 and two lym-
phomas expressed Vfl6 (case 4a, Fig. 1A; and case
14). Three lymphomas expressed Vfl8.1 and/or
Vf18.2 (case 4b, Fig. 1B; and cases 7 and 12). By
using polymerase chain-reaction technology, all
three cases were shown to express the Vf18.2 gene
segment (Fig. 2), and not Vfl8.1. Two of the lym-
phomas appeared to be of biclonal origin (cases 1
and 4). For case 4, this was illustrated by family-
specific antibodies, that is, one identifying the
clone bearing Vfl6 and one identifying the clone
bearing Vfl8.1/2. These two clones differed also
in intensity of CD4 expression and expression of
the CD3/TCR complex, and in tissue localization
(Fig. 1). This rules out the possibility that a fail-
ure in allelic exclusion occurred in this lym-
phoma leading to the expression of two TCR fl
chains on one cell.
In all lymphomas, varying numbers of CD4
and CD8 SP cells occurred with a phenotype dif-
ferent from that of the lymphoma, presumably
representing preexistent T cells. These CD4 and
CD8 SP populations appeared to be present in a
normal CD4/CD8 ratio, compared to the mature
thymocyte and peripheral T-cell population.
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FIGURE 1. Immunoperoxidase .staining of serial cryostat
sections of the lymphomic spleen of case 4 with (a) mAB 44-
22-1 (anti-Vfl6) and (b) mAB KJ16 (anti-Vfl8.1/2). Note the
different localization of the two clones, one bearing Vfl6 and
one bearing Vfl8.1/2.
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FIGURE 2. T-cell receptor fl-chain PCR products from AKR
lymphoma genomic DNA. Lanes and 9:1 kb DNA ladder
(Gibco/BRL, Bethesda, MD); lane 2: case 4, Vfl6; lane 3: case 4,
Vfl8.1; lane 4: case 4, Vf18.2; lane 5: case 7, Vfl8.1; lane 6: case 7,
Vf18.2; lane 7: case 12, Vfl8.1; and lane 8: case 12, Vf18.2.98 CEES DE HEER et al.
DISCUSSION
Of the AKR mice investigated, the predominant
presence of lymphoma cells was shown in all
lymphoid organs. This was accompanied by a
loss of organ structure and presence of only rem-
nants of the preexistent stroma. One case (case
11) was exceptional, as in this case, the lym-
phoma was only restricted to the thymus. Strik-
ingly, this lymphoma represented the most
immature phenotype of all cases studied, sug-
gesting an inability of this lymphoma to migrate
to the periphery possibly due to its arrest in an
immature stage of development. The T-cell lin-
eage origin of the lymphomas was evident from
the expression of the CD3/TCR complex, in all
but one (case 11) of the cases.
CD4 and CD8 phenotyping of the lymphomas
revealed DN (CD4-8-), DP (CD4/8/), and SP
(CD4/8 or CD4-8/) lymphomas. The percentages
of these different phenotypes (30%, CD4-8-; 13%,
CD4+8/; 38%, CD4/8-; and 19%, CD4-8/) did not
correspond to the percentages of these popu-
lations in the normal AKR thymus, that is, 4%,
81%, 10%, and 5%, respectively (Fig. 3). This is
especially true for the DP phenotype.
io % 81%
. 5 %
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FIGURE 3. Expression of CD4 and CD8 differentiation
antigens on normal AKR thymocytes. The percentages given
indicate the percentage of gated cells falling within the
quadrant of the two-dimensional contour plot.
The present phenotype distribution among the
lymphomas deviates from the findings of Richie
et al. (1988), who found a more frequent occur-
rence of immature phenotypes (CD4-8- and
CD4/8/) in a series of 12 naturally occurring AKR
lymphomas. Combined with our data, there is no
prevalent phenotype of the AKR lymphomas.
This may suggest that there is no distinct pheno-
type that is particularly susceptible for lympho-
magenesis. However, other data in fact do
indicate a preferential phenotype of AKR lym-
phomas. Within the different populations based
on CD4/CD8 phenotype, there was a large het-
erogeneity in the intensity of expression of the
CD3, CD4, and CD8 antigens. There was no com-
mon pattern in the expression levels of the
various markers on any of the lymphomas (Table
1). This variability in CD3, CD4, and CD8
expression suggests a random loss of membrane
antigens. Such a loss of cell membrane markers is
well-known for T-cell neoplasms (Schuurman et
al., 1991). It is therefore tempting to speculate
that most of the SP lymphomas are derived from
a DP lymphomic progenitor, and hence the num-
ber of DP lymphomas in this study may be an
underestimate of the real value. The expression
of CD3 on the DN lymphoma cells is in line with
this explanation. These observations point to the
possibility that the immature DP stage of T-cell
development is the target for the induction of the
lymphomagenesis, with subsequent antigenic
loss and development of SP, DN, or even CD3-
cases of lymphoma, and that therefore there may
be a preferential phenotype of AKR lymphomas.
The expression of the TCR ]/-chain variable
gene segment Vfl6 on the cell surface of two lym-
phoma cases also points to lymphomagenesis at
the immature DP stage of T-cell development.
Normally, in AKR mice, thymocytes expressing a
V]/6 TCR are deleted at that stage from the thym-
ocyte pool in AKR mice (MacDonald et al.,
1988b). Two out of 14 lymphomas tested (cases 4a
and 14) expressed a V]/6
/ TCR. Both were of the
CD4/8 phenotype (Table 1), which suggests that
these lymphomas belong to the "forbidden"
CD4
/ autoreactive population (MacDonald et al.,
1988a). Three lymphomas expressed a TCR
stained by mAB KJ16, recognizing a shared epi-
tope on Vfl8.1 and Vf18.2 (V]/8.1 being
"forbidden"). In genomic DNA analysis, all three
KJ16
/ lymphomas expressed the V]/8.2 TCR (Fig.
2), which is not autoreactive. Therefore, only theVfl USAGE IN AKR LYMPHOMAS 99
two V]/6 expressing lymphomas are potentially
autoreactive.
During T-cell development, positive selection
precedes negative selection (Blackman et al.,
1990b; Ramsdell and Fowlkes, 1990). The pres-
ence of the Vj6+CD4+ lymphomas indicates that
the lymphomagenesis occurs after or during
positive selection, but before negative selection.
This implies that interaction between precursors
of lymphoma cells and the thymic microenviron-
ment was not effective in creating negative selec-
tion of V]/6+CD4
+ cells. In view of the unexpected
high frequency of "forbidden" V]/6
+ lymphomas
(two out of six definable cases), it seems that this
interaction, which involves the CD3/TCR com-
plex, MHC determinants, and the CD4 accessory
molecule, may have resulted in stimulation
rather than deletion. This is plausible because the
same molecules are involved in intrathymic posi-
tive and negative selection. Such stimulatory sig-
nals may also be involved in the generation of the
rather high proportion of biclonal lymphomas
(two out of fourteen). In case 4, one member is
indeed Vfl6/.
Despite the presence of potentially auto-
reactive cells, there were no indications for auto-
immune reactions in the animals. Several expla-
nations can be given for this phenomenon. The
lack of autoreactivity can be due to shortcomings
in the functional properties of the V]/6
+ lym-
phoma cells. Because’the lymphoma cells most
likely arose from an immature DP (CD4+CD8/)
thymocyte, they have probably not been posi-
tively selected. Another possibility is that a loss
of other essential memblane antigens, for
example, those involved in cellular adhesion,
underlies a diminished autoreactive capacity. It
is also possible that the stimulatory Mls-1
antigens are not sufficiently expressed in the
lymphomic lymphoid organs. Finally, clonal
anergy to explain tolerance is seen in some
(experimental) conditions (Rammensee et al.,
1989; Blackman et al., 1990a). In this case, pre-
sumably autoreactive cells are blocked for their
reactivity and hence do not mediate autoreac-
tions and autoimmune symptoms. Clonal anergy
is however not the most prominent way of nat-
urally occurring tolerance to Mls-1 antigens
(Rammensee et al., 1989; Bl.ackman et al., 1990a).
In conclusion, our present findings suggest
that lymphomagenesis in AKR mice occurs pre-
dominantly at the immature DP stage of T-cell
development. This is followed by a defective
clonal deletion in the lymphomic thymus and
results in the generation of T cells with the
phenotype of potentially autoreactive cells. These
are the first data indicating a failure of the thy-
mic deletion system under nonphysiological
conditions.
MATERIALS AND METHODS
Mice
Male AKR/FuRdARij specific pathogen-free
mice of 8-10 weeks old were obtained from the
Central Animal Facility of the TNO Institute for
Applied Radiobiology and Immunology,
Rijswijk, The Netherlands. They were kept under
clean conventional conditions. Spontaneous lym-
phomas were obtained from untreated mice at
the age of 6 months or older.
(Immuno-)histochemistry
At autopsy, thymus, spleen, and mesenteric
lymph nodes were harvested and snap frozen in
liquid nitrogen. For conventional light
microscopy, 8-/m sections were stained with
hematoxylin and eosin. For immunohistochemis-
try, 6-/m sections were fixed in acetone for
10 min at room temperature and then.incubated
with the first mAB. CD3 expression was detected
using mAB YCD3-1 (Portoles et al., 1989) (a gift
of Dr. K. Bottomly, Yale University School of
Medicine, New Haven, CT). CD4 and CD8
antigens were determined using mAB MT4
(Pierres et al., 1984) and Lyt-2 (Ledbetter and
Herzenberg, 1979), respectively (provided by Dr.
G. Kraal, Free University, Amsterdam, The
Netherlands). TCR V// usage was determined
using mAB 44-22-1 (V]/6 [Payne et al., 1988]; a
gift of Dr. R. Schneider, University Hospital, Zur-
ich, Switzerland), mAB KJ16 (V/8.1 and V//8.2
[Haskins et al., 1984]) and mAB KJ25 (V/3
[Pullen et al., 1988]), both provided by Drs. J. W.
Kappler and P. Marrack, Howard Hughes Medi-
cal Institute, Denver, CO. The primary mABs
were detected using an indirect method. YCD3-1,
MT4, Lyt-2, 44-22-1, and KJ16 were used in com-
bination with goat antirat IgG conjugated to hor-
seradish peroxidase (Jackson Immunoresearch
Laboratories, West Grove, PA) and rabbit anti-100 CEES DE HEER et al.
goat Ig conjugated to horseradish peroxidase
(Dakopatts, Glostrup, Denmark). Binding of KJ25
was detected using a combination of rabbit anti-
hamster IgG conjugated to biotin, with sub-
sequent detection by streptavidin-peroxidase
(both from Jackson Immunoresearch
Laboratories). Peroxidase activity was developed
by 3,3-diaminobenzidine tetrahydrochlorid
(DAB) with H202 as the substrate. The sections
were counterstained with haematoxylin.
Cytofluorographics
Cytofluorographic staining of thymocyte-cell
suspensions from normal AKR mice was done
using CD4 mAB GK1.5 (Dialynas et al., 1983)
conjugated with biotin in combination with
streptavidin-phycoerythrin. For CD8, mAB 53-6.7
(Becton Dickinson, Sunnyvale, CA) directly con-
jugated to FITC was used. Analysis of 106
cells/mL was done using a FACScan (Becton
Dickinson).
Genomic DNA Analysis
Genomic DNA was isolated from cell suspen-
sions by proteinase K digestion, precipitated
with ethanol and redissolved in TRIS/EDTA, pH
8.0. Polymerase chain reaction (PCR) amplifi-
cation was perfolaned in a reaction buffer con-
sisting of 50mM KC1, 10mM TRIS (pH 8.4),
4.0mM MgC12, bovine serum albumin (100
/g/mL), each deoxyribonucleotide (dNTP) at
0.2mM (Pharmacia, Uppsala, Sweden), 2 tg of
AKR genomic spleen DNA, 100-300 ng of each of
two oligonucleotide primers and 1 U of Taq DNA
polymerase (Gibco/BRL, Bethesda, MD) in a
total volume of 50 tL. The primers are based on
known nucleotide sequences of murine T-cell
receptor genes (Chien et al., 1984; Gascoigne et
al., 1984; Patten et al., 1984; Chou et al., 1987):
V]/6: ACTGAAAACGATCTTCAAAA; V]/8.1:
GTCGCTGACAGCACGGAGAA; V]/8.2: GCTC-
TTCTTCGTGCTCTCCAG, and a primer comp-
lementary to a conserved region of the J]/clus-
ters: mJfll: GAAACCAGGTCCGTGGTC. The
reactions were performed for 35 cycles of denat-
uration (1 min at 94 C), annealing (1 min at
60 C), and extension il min at 72 C). The PCR
products were analyzed by agarose gel electro-
phoresis, and had a size, based on their location
in the agarose gel, that was in agreement with the
published sequences.
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